Release Notes

Item

Update

December 2022  

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen

Updated

I - Activity Level Reporting (ALR) - Appendix -  Appendix 1.14 - NHPIP Code List

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 -  STFM Drug Classification - Antineoplastic and Supportive Drug list

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol

I - Activity Level Reporting (ALR) - Specifications - ALR - Submission Schedule FY 2022/2023 - ALR Special Resubmission Request Form

January 2023

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen

X - Symptom Management - Symptom Management - Tobacco Use Survey - Quit Methods - Valid Values

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 -  STFM Drug Classification - Antineoplastic and Supportive Drug list

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol

I - Activity Level Reporting (ALR) - Radiation Planning/Treatment Activity - Dose per Fraction - Definition

I - Activity Level Reporting (ALR) - Specifications - Submission Specifications - Data Selection Criteria - Submission Removal

I - Introduction - Frequently Asked Questions (FAQ) about Data Book - #13

February 2023

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 -  STFM Drug Classification - Antineoplastic and Supportive Drug list

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol

I - Activity Level Reporting (ALR) - Appendix -  Appendix 1.14 - NHPIP Code List

I - Activity Level Reporting (ALR) - Appendix -  Appendix 1.36 - ICDO3 Morphology Codes

March 2023

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 -  STFM Drug Classification - Antineoplastic and Supportive Drug list

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.39 - Clinical Practice Group Mapping

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen

April 2023

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 -  STFM Drug Classification - Antineoplastic and Supportive Drug list

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.1 - OHRS Functional Centres - Title

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.1 - MIS Functional Centres - OHRS - MIS Functional Centres

I - Activity Level Reporting (ALR) - Appendix - Appendix A - MOHLTC Master Numbering System

May 2023

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.32 - AJCC 9 - Stage Validation Tables - Appendix 1-32-1: AJCCv9 Stage Protocol Key and Description

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.32 - AJCC 9 - Stage Validation Tables - Appendix 1-32-2: ICDO3 Topography/Histology and AJCCv9 Protocol Key

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.32 - AJCC 9 - Stage Validation Tables - Appendix 1-32-3: AJCCv9 Stage Protocol Key and Valid Cancer Stage

June 2023

I - Introduction - Frequently Asked Questions (FAQ) about Data Book - #13

I - Introduction - Frequently Asked Questions (FAQ) about Data Book - #22

I - Activity Level Reporting (ALR) - Specifications - ALR - Submission Schedule FY 2023/2024

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol

July 2023

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.40 - ALR activity by Reporting Facility

August 2023

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.40 - ALR activity by Reporting Facility - Title

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.39 - Clinical Practice Group Mapping

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.36 - ICDO3 Morphology Codes

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.46 - Radiation Treatment (RT) Protocol

September 2023

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen and NCT List - NCT List

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 -  STFM Drug Classification - Antineoplastic and Supportive Drug list

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.39 - Clinical Practice Group Mapping

I - Activity Level Reporting (ALR) - Specifications - ALR - Submission Schedule FY 2023/2024

I - Activity Level Reporting (ALR) - Specifications - QA Specifications - Process Description

October 2023

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.22 - CCO Regimen and NCT List - CCO Regimen Codes

I - Activity Level Reporting (ALR) - Appendix - Appendix 1.43 -  STFM Drug Classification - Antineoplastic and Supportive Drug list